Available in the EU, UK, and Switzerland, the device is designed for in-office preparation of autologous PRP and Fluid-PRF.
Croma-Pharma, focused on minimally invasive aesthetic medicine, announced the launch of its new medical device, Exprecell, which is used for the preparation of autologous platelet-rich plasma (PRP) and fluid-platelet-rich fibrin (Fluid-PRF).
Exprecell is now available for healthcare professionals in the EU, UK, and Switzerland.
According to the company, the device enables the preparation of autologous blood concentrates without the use of anticoagulants, resulting in Fluid-PRFโa biologically active concentrate that retains platelet and leukocyte regenerative properties while remaining liquid for a defined period.
Exprecell is MDR-certified and compatible with Luer-Lock syringes to support flexible system integration and secure fluid transfer. It features a closed-system design intended to limit exposure to external contaminants and uses a single-spin process to prepare autologous PRP and Fluid-PRF from whole blood, with a five-minute spin time at 420รg.
ID 136822513 ยฉ ะะฒะณะตะฝะธะน ะะตััะธะฝะธะฝ | Dreamstime.com
